...
首页> 外文期刊>Journal of Clinical Microbiology >Evaluation of a murine model of hepatic candidiasis.
【24h】

Evaluation of a murine model of hepatic candidiasis.

机译:评价肝念珠菌病的鼠模型。

获取原文
           

摘要

A murine model of focal hepatic candidiasis which we suggest simulates certain conditions of this clinical variant of systemic candidiasis in leukemic patients is described. We have shown that outbred mice inoculated with Candida albicans by the oral-intragastric route as infants (6 days old) and then immunocompromised by cyclophosphamide and cortisone acetate treatment 2 weeks later demonstrate systemic spread of the opportunistic pathogen to the liver, lungs, spleen, and kidneys. Treatment with the immunosuppressive drugs cyclophosphamide and cortisone acetate resulted in alteration of the normal integrity of the mucosal epithelium of the gut as well as in granulocytopenia. Approximately 55% of the animals with C. albicans infections in the liver demonstrated hepatic abscesses. After these same infected, immunocompromised animals were treated with suboptimal dosages of antifungal agents (cilofungin or amphotericin B), either by intraperitoneal or subcutaneous (s.c.) routes, persistent hepatic abscesses were fewer in number and delimited by a distinct outer layer of host tissue but still contained large numbers of the viable pathogen. Blood cell counts indicated that these antifungal drug-treated animals had reestablished approximately the same number of leukocytes per microliter of blood as estimated prior to the immunocompromising drug treatment. Similar conditions in leukemic patients who were in remission and who were undergoing antifungal drug therapy for systemic candidiasis have been reported. Clearance of hepatic infections in mice was accomplished by using appropriate concentrations of amphotericin B administered by daily intraperitoneal or s.c. injection for 5 to 7 days or cilofungin by continuous s.c. infusion for 7 days. However, systemic antifungal therapy did not significantly reduce numbers of C. albicans cells in the stomach and esophagus. Persistent foci of gastrointestinal colonization by C. albicans, especially in the region of the cardial-atrium fold of the stomach of these mice, are reservoirs of the opportunistic pathogen from which reinfection may occur, leading to relapse of systemic candidiasis.
机译:我们提出了一种局灶性肝念珠菌病的小鼠模型,我们建议该模型模拟白血病患者中这种系统性念珠菌病临床变异的某些情况。我们已经证明,在婴儿(6天大)时通过口服-胃内途径接种了白色念珠菌的近交小鼠,然后在2周后被环磷酰胺和醋酸可的松治疗免疫受损,证明机会病原体已全身扩散至肝脏,肺脏,脾脏,和肾脏。用免疫抑制药环磷酰胺和醋酸可的松治疗可导致肠道粘膜上皮以及粒细胞减少症的正常完整性发生改变。肝中约有55%的白色念珠菌感染动物表现出肝脓肿。在这些相同的感染后,免疫力低下的动物通过腹膜内或皮下(sc)途径用次适量的抗真菌剂(西洛芬净或两性霉素B)治疗,持续性肝脓肿的数量较少,并由宿主组织的独特外层界定,但仍然含有大量可行的病原体。血细胞计数表明,这些抗真菌药物治疗的动物每毫升微升血液重建的白细胞数目与免疫损害药物治疗之前估计的数目大致相同。据报道,缓解的白血病患者和正在接受抗真菌药物治疗的全身性念珠菌病患者的情况相似。通过每天腹膜内或皮下注射适量的两性霉素B来清除小鼠的肝感染。连续s.c.注射5至7天或西洛芬净。输液7天。但是,全身性抗真菌治疗并未显着减少胃和食道中白色念珠菌细胞的数量。白色念珠菌在胃肠道中的持久性病灶,尤其是在这些小鼠的胃的心脏-心房褶皱区域中,是机会病原体的储库,可能会从该病原体中发生再感染,导致系统性念珠菌病复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号